-transparent.png){kind=logo}
The effectiveness of a single 300-mg dose of tosufloxacin and of 3-day treatment with tosufloxacin (300 mg daily) were compared in a prospective trial in order to clarify the cost-effectiveness of tosufloxacin for acute uncomplicated cystitis. Fifty female patients (25 patients of each group) with acute uncomplicated cystitis received one of these treatment regimens, and the clinical data and follow-up culture results were analyzed. The effectiveness rates of single-dose treatment and 3-day treatment after 3 days were 100% and 96%, respectively. The recurrence rates of single-dose treatment and 3-day treatment after 14 or 28 days were 0% (0/13 patients) and 15% (2/13 patients), respectively. There was no significant difference in the effectiveness rate and the recurrence rate between these two groups, statistically. All isolated strains were eliminated in both regimens. From these results, it is suggested that single-dose treatment of tosufloxacin is effective enough for acute uncomplicated cystitis.
H Kiyota, and
T Machida, and
F Masuda, and
Y Ohishi, and
S Onodera, and
H Suzuki, and
H Goto, and
M Kawahara, and
H Igarashi, and
K Endou
January 1992,
Infection,
H Kiyota, and
T Machida, and
F Masuda, and
Y Ohishi, and
S Onodera, and
H Suzuki, and
H Goto, and
M Kawahara, and
H Igarashi, and
K Endou
April 1992,
Hinyokika kiyo. Acta urologica Japonica,
H Kiyota, and
T Machida, and
F Masuda, and
Y Ohishi, and
S Onodera, and
H Suzuki, and
H Goto, and
M Kawahara, and
H Igarashi, and
K Endou
October 1992,
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H Kiyota, and
T Machida, and
F Masuda, and
Y Ohishi, and
S Onodera, and
H Suzuki, and
H Goto, and
M Kawahara, and
H Igarashi, and
K Endou
February 1999,
Hinyokika kiyo. Acta urologica Japonica,
H Kiyota, and
T Machida, and
F Masuda, and
Y Ohishi, and
S Onodera, and
H Suzuki, and
H Goto, and
M Kawahara, and
H Igarashi, and
K Endou
January 1986,
Lakartidningen,
H Kiyota, and
T Machida, and
F Masuda, and
Y Ohishi, and
S Onodera, and
H Suzuki, and
H Goto, and
M Kawahara, and
H Igarashi, and
K Endou
January 1991,
Drugs,
H Kiyota, and
T Machida, and
F Masuda, and
Y Ohishi, and
S Onodera, and
H Suzuki, and
H Goto, and
M Kawahara, and
H Igarashi, and
K Endou
September 1999,
Cleveland Clinic journal of medicine,
H Kiyota, and
T Machida, and
F Masuda, and
Y Ohishi, and
S Onodera, and
H Suzuki, and
H Goto, and
M Kawahara, and
H Igarashi, and
K Endou
February 1992,
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H Kiyota, and
T Machida, and
F Masuda, and
Y Ohishi, and
S Onodera, and
H Suzuki, and
H Goto, and
M Kawahara, and
H Igarashi, and
K Endou
January 1999,
International journal of fertility and women's medicine,
H Kiyota, and
T Machida, and
F Masuda, and
Y Ohishi, and
S Onodera, and
H Suzuki, and
H Goto, and
M Kawahara, and
H Igarashi, and
K Endou
September 2005,
The Pediatric infectious disease journal,
